Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy

References

• Bron D, Ades L, Fulop T, et al. Aging and blood disorders: new perspectives, new challenges. Haematologica. 2015;100:415–417.
   PubMed Web of Science ®Google Scholar
• seer.cancer.gov. 2013. Ref Type: Online Source.
   Google Scholar
• Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–2067.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Stauder R, van Munster BC. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist. 2014;19:1069–1075.
   PubMed Web of Science ®Google Scholar
• Stauder R. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Ann Hematol. 2012;91:1333–1343.
   PubMed Web of Science ®Google Scholar
• Wildiers H. Siog consensus on geriatric assessment in older cancer patients. J Geriatr Oncol. 2014;5:S1–S2.
   Google Scholar
• Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol a Biol Sci Med Sci. 2007;62:722–727.
   PubMed Web of Science ®Google Scholar
• Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58:681–687.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Mitnitski A, Song X, et al. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc. 2006;54:975–979.
   PubMed Web of Science ®Google Scholar
• Extermann M, Meyer J, McGinnis M, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol. 2004;49:69–75.
   PubMed Web of Science ®Google Scholar
• Terret C, Albrand G, Droz JP. Multidisciplinary geriatric assessment reveals unknown medical problems in elderly cancer patients. J Clin Oncol. 2004;22:8167.
   Google Scholar
• Wedding U, Kodding D, Pientka L, et al. Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol. 2007;64:1–9.
   PubMed Web of Science ®Google Scholar
• Wildiers H, Heeren P, Puts M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595–2603.
   PubMed Web of Science ®Google Scholar
• Valentiny C, Kemmler G, Stauder R. Age, sex and gender impact multidimensional geriatric assessment in elderly cancer patients. J Geriatr Oncol. 2012;3:17–23.
   Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
   PubMed Web of Science ®Google Scholar
• Sheikh JI, Yesavage JA, Brooks JO. III, et al. Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr. 1991;3:23–28.
   PubMedGoogle Scholar
• Barthel D. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65.
   PubMedGoogle Scholar
• Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186.
   PubMed Web of Science ®Google Scholar
• Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test . Arch Phys Med Rehabil. 1986;67:387–389.
   PubMed Web of Science ®Google Scholar
• Fydich F, Sommer G, Brahler E. F-SozU: Fragebogen zur sozialen Unterstutzung. Göttingen, Germany: Hogrefe Verlag GmbH & Co.; 2007.
   Google Scholar
• Swerdlow SH, Campo E, Harris NL et al. WHO classification of tumours of haematopoietic and lymphoid tissue. Lyon: IARC; 2008.
   Google Scholar
• Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41:237–248.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Hirakawa T, Inokuchi K. Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma. J Clin Exp Hematop. 2011;51:1–5.
   PubMedGoogle Scholar
• Oberaigner W. Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med. 2007;46:420–424.
   PubMed Web of Science ®Google Scholar
• Marchesi F, Cenfra N, Altomare L, et al. A retrospective study on 73 elderly patients (>/=75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment. J Geriatr Oncol. 2013;4:242–248.
   PubMed Web of Science ®Google Scholar
• Merli F, Luminari S, Rossi G, et al. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi. Leuk Lymphoma. 2014;55:38–43.
   PubMed Web of Science ®Google Scholar
• Aaldriks AA, Giltay EJ, Nortier JW, et al. Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56:927–935.
   PubMed Web of Science ®Google Scholar
• Tucci A, Martelli M, Rigacci L, et al. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Leuk Lymphoma. 2015;56:921–926.
   PubMed Web of Science ®Google Scholar
• Tucci A, Ferrari S, Bottelli C, et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer. 2009;115:4547–4553.
   PubMed Web of Science ®Google Scholar
• Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. J Clin Oncol.2011;29:3457–3465.
   PubMed Web of Science ®Google Scholar
• Wildes TM, Ruwe AP, Fournier C, et al. Geriatric assessment is associated with completion of chemotherapy, toxicity and survival in older adults with cancer. J Geriatr Oncol. 2013;4:227–234.
   PubMed Web of Science ®Google Scholar